HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedNCT03593213

Safety study of cariprazine in schizophrenia

This study was terminated in the United States, in Bulgaria, in Malaysia, .... It is testing cariprazine for schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Cariprazine may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Bulgaria, in Malaysia, and in Poland.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: July 30, 2018
Recruitment status
Terminated
Enrollment listed in the registry
587
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Malaysia, ...
Age range
From 18 Years to 64 Years
Official registry ID
NCT03593213
Official title
A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT03593213. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Bulgaria · 10 sites
  • Mental Health Centre - Prof.Dr.Ivan Temkov-Burgas
    Burgas
    Site status: Not listed — confirm with the team
  • State Psychiatry Hospital
    Kardzhali
    Site status: Not listed — confirm with the team
  • MHAT Dr. Hristo Stambolski" EOOD; Department of Psychiatry
    Kazanlak
    Site status: Not listed — confirm with the team
  • State Psyciiatric Hospital - Lovech
    Lovech
    Site status: Not listed — confirm with the team
  • UMHAT Dr. Georgi Stranski, EAD
    Pleven
    Site status: Not listed — confirm with the team
  • Mental health Centre-Ruse EOOD
    Rousse
    Site status: Not listed — confirm with the team
  • MHAT-Targovishte, AD
    Targovishte
    Site status: Not listed — confirm with the team
  • DCC Mladost M - Varna, OOD
    Varna
    Site status: Not listed — confirm with the team
  • Mental Health Center - Veliko Tarnovo EOOD, Veliko Tarnovo
    Veliko Tarnovo
    Site status: Not listed — confirm with the team
  • Mental Health Center - Vratsa EOOD, Vratsa
    Vratsa
    Site status: Not listed — confirm with the team
Malaysia · 3 sites
  • University Kuala Lumpur
    Ipoh
    Site status: Not listed — confirm with the team
  • University Malaya Medical Center
    Kuala Lumpur
    Site status: Not listed — confirm with the team
  • Hospital Sentosa
    Kuching
    Site status: Not listed — confirm with the team
Poland · 5 sites
  • Szpital Uniwersytecki Nr.1 im. Dr. A. Jurasza, Klinika Psychiatrii
    Bydgoszcz
    Site status: Not listed — confirm with the team
  • Samodzielny Publiczny Zespół Opieki Zdrowotnej
    Chełmno
    Site status: Not listed — confirm with the team
  • Centrum Badan Klinicznych PI-House
    Gdansk
    Site status: Not listed — confirm with the team
  • Specjalistyczna Praktyka lekarska
    Lublin
    Site status: Not listed — confirm with the team
  • Indywidualna Specjalistyczna Praktyka
    Poznan
    Site status: Not listed — confirm with the team
Puerto Rico · 1 site
  • INSPIRA Clinical Research
    San Juan
    Site status: Not listed — confirm with the team
Romania · 5 sites
  • Spitalul de Psihiatrie si Neurologie Brasov
    Brasov
    Site status: Not listed — confirm with the team
  • Spitalul de Psihiatrie TITAN "Dr. Constantin Gorgoș", Bulevardul Nicolae Grigorescu, Nr. 41
    Bucharest
    Site status: Not listed — confirm with the team
  • Armys Clinical Emergency Central Hospital Prof Dr Carol Davila
    Bucharest
    Site status: Not listed — confirm with the team
  • CETTT SF Stelian Hospital
    Bucharest
    Site status: Not listed — confirm with the team
  • Spital Clinic Judetean Tg. Mures
    Târgu Mureş
    Site status: Not listed — confirm with the team
Serbia · 8 sites
  • Clinical Center of Serbia
    Belgrade
    Site status: Not listed — confirm with the team
  • Clinical Hospital Center Dr. Dragisa Misovic-Dedinje
    Belgrade
    Site status: Not listed — confirm with the team
  • Institute of Mental Health
    Belgrade
    Site status: Not listed — confirm with the team
  • Special Hospital for Psychiatric Diseases "Kovin"
    Kovin
    Site status: Not listed — confirm with the team
  • Clinical Centre Kragujevac
    Kragujevac
    Site status: Not listed — confirm with the team
  • Clinical Centre Kragujevac
    Kragujevac
    Site status: Not listed — confirm with the team
  • Specialized Hospital for Neuropsychiatric Diseases Sveti Vracevi
    Novi Kneževac
    Site status: Not listed — confirm with the team
  • Clinic for Psychiatry, Clinical Centre of Vojvodina
    Novi Sad
    Site status: Not listed — confirm with the team
South Korea · 5 sites
  • Inje University Busan Paik Hospital
    Busan
    Site status: Not listed — confirm with the team
  • Inje University Heaundae Paik Hospital
    Busan
    Site status: Not listed — confirm with the team
  • Chonnam National University Hospital
    Gwangju
    Site status: Not listed — confirm with the team
  • Gachon University Gil Medical Center
    Incheon
    Site status: Not listed — confirm with the team
  • Jeju National University Hospital
    Jeju City
    Site status: Not listed — confirm with the team
Taiwan · 3 sites
  • Taipei Tzu Chi Hospital
    New Taipei City
    Site status: Not listed — confirm with the team
  • National Cheng Kung University Hospital
    Tainan
    Site status: Not listed — confirm with the team
  • Department of Psychiatry, Taipei Veterans General Hospital, Taiwan
    Taipei
    Site status: Not listed — confirm with the team
Thailand · 1 site
  • Suan prung Psychiatric Hospital
    Nonthaburi
    Site status: Not listed — confirm with the team
Ukraine · 14 sites
  • Regional Psychonevrological Hospital #3
    Ivano-Frankivsk
    Site status: Not listed — confirm with the team
  • Kharkiv regional clinical psychiatric hospital #3
    Kharkiv
    Site status: Not listed — confirm with the team
  • Institute of Neurology, Psychiatry and Narcology of the NAMS of Ukraine
    Kharkiv
    Site status: Not listed — confirm with the team
  • SI Institute of Neurology, Psychiatry and Narcology of NAMSU
    Kharkiv
    Site status: Not listed — confirm with the team
  • Kyiv Railway Clinical Hospital #2 of Branch "Health Center" of the Public Joint Stock Company "Ukrainian Railway"v
    Kyiv
    Site status: Not listed — confirm with the team
  • Kyiv Regional Medical Incorporation "Psychiatry"
    Kyiv
    Site status: Not listed — confirm with the team
  • Geikivka multidisciplinary hospital for psychiatric care
    Kyiv
    Site status: Not listed — confirm with the team
  • KNP of Lviv Regional Council "Lviv Regional Clinical Psychiatric Hospital"
    Lviv
    Site status: Not listed — confirm with the team
  • Odessa Regional Medical Centre of Mental Health
    Odesa
    Site status: Not listed — confirm with the team
  • Odesa Regional Psychiatric Hospital No.2 of the ORC
    Odesa
    Site status: Not listed — confirm with the team
  • Kherson Regional Psychiatric Institution for Psychiatric Care
    Petrivka
    Site status: Not listed — confirm with the team
  • Cherkasy regional psychiatric hospital of the CRC
    Smila
    Site status: Not listed — confirm with the team
  • CI O.I. Yuschenko VRPsH Depts No.14 and No.15 M.I. Pyrogov VNMU
    Vinnytsia
    Site status: Not listed — confirm with the team
  • VNMU
    Vinnytsia
    Site status: Not listed — confirm with the team
United States · 42 sites
  • Pillar Clinical Research
    Bentonville, Arkansas
    Site status: Not listed — confirm with the team
  • Woodland International Research Group
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Woodland Research Northwest, LLC
    Rogers, Arkansas
    Site status: Not listed — confirm with the team
  • Advanced Research Center, Inc.
    Anaheim, California
    Site status: Not listed — confirm with the team
  • CITrials - Bellflower
    Bellflower, California
    Site status: Not listed — confirm with the team
  • Synexus Clinical Research US, Inc.
    Cerritos, California
    Site status: Not listed — confirm with the team
  • ATP Clinical Research, Inc.
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • California Pharmaceutical Research Institute, Inc.
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • ProScience Research Group
    Culver City, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Research Network, LLC.
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Behavioral Research Specialists, LLC
    Glendale, California
    Site status: Not listed — confirm with the team
  • Omega Clinical Trials
    La Habra, California
    Site status: Not listed — confirm with the team
  • Synergy San Diego
    Lemon Grove, California
    Site status: Not listed — confirm with the team
  • Alliance Research
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Excell Research, Inc
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Orange County Neuropsychiatric Research Center, LLC
    Orange, California
    Site status: Not listed — confirm with the team
  • CNRI-Los Angeles
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • University of California San Diego
    San Diego, California
    Site status: Not listed — confirm with the team
  • Schuster Medical Research Institute
    Sherman Oaks, California
    Site status: Not listed — confirm with the team
  • Collaborative Neuroscience Research, LLC
    Torrance, California
    Site status: Not listed — confirm with the team
  • Wilks & Safirstein MD PA D/B/A MD Clinical
    Hallandale, Florida
    Site status: Not listed — confirm with the team
  • Southern Winds Hospital
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Research Centers of America
    Hollywood, Florida
    Site status: Not listed — confirm with the team
  • Synexus Clinical Research, Inc
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • iResearch Atlanta LLC
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Atlanta Behavioral Research, LLC
    Dunwoody, Georgia
    Site status: Not listed — confirm with the team
  • AMITA Health Alexian Brothers Center for Psychiatric Research
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Louisiana Clinical Research
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • CBH Health LLC
    Gaithersburg, Maryland
    Site status: Not listed — confirm with the team
  • Altea Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Alea Research Institute
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Hassman Research Institute
    Berlin, New Jersey
    Site status: Not listed — confirm with the team
  • Neurobehavioral Research, Inc.
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • New Hope Clinical Research
    Charlotte, North Carolina
    Site status: Not listed — confirm with the team
  • Clinical Inquest Center Ltd.
    Beavercreek, Ohio
    Site status: Not listed — confirm with the team
  • OSY Psychiatry Department
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Professional Psychiatric Services
    Mason, Ohio
    Site status: Not listed — confirm with the team
  • Sooner Clinical Research
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Community Clinical Research, Inc.
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research
    Richardson, Texas
    Site status: Not listed — confirm with the team
  • Pillar Healthcare
    Richardson, Texas
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Cariprazine, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 64 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.